|
CSNK1G1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.63109978249076E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.940800E-01 |
| Stage1-vs-Stage3 |
3.003400E-01 |
| Stage1-vs-Stage4 |
7.618900E-04 |
| Stage2-vs-Stage3 |
1.262050E-01 |
| Stage2-vs-Stage4 |
2.103500E-03 |
| Stage3-vs-Stage4 |
4.511700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.96679999643035E-08 |
| Normal-vs-Asian |
1.62470037423645E-12 |
| Caucasian-vs-AfricanAmerican |
2.206600E-01 |
| Caucasian-vs-Asian |
2.586800E-01 |
| AfricanAmerican-vs-Asian |
4.000200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.031400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.06600000000057E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.654800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.571000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.201200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.785600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.958800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.299400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.379800E-03 |
| Classical-VS-Follicular |
5.609000E-01 |
| Classical-VS-Other |
1.166450E-01 |
| Classical-VS-Normal |
1.92068583260152E-14 |
| Tall-VS-Follicular |
2.660800E-03 |
| Tall-VS-Other |
9.456600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.188000E-02 |
| Follicular-VS-Normal |
4.93699525705438E-11 |
| Other-VS-Normal |
2.01590000004082E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.760800E-03 |
|
|
